ArticleNeurophotonics2025
Optical attenuation coefficient decorrelation-based optical coherence tomography angiography for microvascular evaluation of Alzheimer's disease on mice.
Article in Neurophotonics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Preclinical in-vivo cerebrovascular imaging in rodent models: Methods and applications in Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026Review
- Structure-Aware OCTA Segmentation for OCTA-Derived Quantitative Analysis of Cerebral Microvascular Perfusion in Ischemic Stroke.Tomography (Ann Arbor, Mich.) · 2026Article
- AI reshaping life sciences: intelligent transformation, application challenges, and future convergence in neuroscience, biology, and medicine.Frontiers in digital health · 2025Review
- Molecular mechanisms and multi-target therapeutic strategies of diabetic nephropathy: from pathogenesis to precision interventions.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: The deep cortical microvasculature is closely linked to the pathogenesis of Alzheimer's disease (AD). However, tail artifacts from superficial cortical vessels often interfere with detecting deep vessels in optical coherence tomography angiography (OCTA) imaging. A more accurate method to assess deep cortical vasculature is crucial for understanding its relationship with AD onset. Aim: We aim to reduce superficial vessel artifacts in OCTA imaging and improve the visualization and analysis of deep cortical microvasculature in an AD mouse model. Approach: We introduced the optical attenuation coefficient decorrelation (OACD) method for OCTA, effectively reducing tail artifacts from superficial cortex vessels. This method was used to visualize and quantitatively analyze deep cortical microvasculature Results: The OACD method significantly reduced superficial vessel artifacts, leading to clearer imaging of the deep cortical vasculature. Quantitative analysis revealed that changes in the deep cortical microvasculature were more pronounced than in the superficial vasculature, suggesting a more direct involvement of the deep vessels in AD progression. Conclusions: The proposed OACD method enhances OCTA imaging by reducing tail artifacts from superficial vessels, facilitating improved assessment of deep cortical microvasculature. These findings suggest that deep cortical vascular changes may play a key role in the pathogenesis of AD, offering potential insights for early detection and monitoring of AD progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.